ArticleJournal of the International Association of Providers of AIDS Care

Safety and Efficacy of Dolutegravir Plus Rilpivirine in Treatment-Experienced HIV-Infected Patients: The DORIVIR Study.

Rosario Palacios et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.